PMA P240044S001

Device
Globe® Catheter and Globe® Pulsed Field System
Applicant
Kardium, Inc.
PMA number
P240044
Supplement
S001
Product code
QZI
Decision date
2026-06-23
Classification
Cardiovascular
Generic name
Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation
Approval order statement
approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P240044

Current openFDA PMA Record#

Device
Globe® Catheter and Globe® Pulsed Field System
Applicant
Kardium, Inc.
PMA number
P240044
Supplement
S001
Product code
QZI
Generic name
Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation
Decision date
2026-06-23
Decision code
APPR
Date received
2025-09-29
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Approval order statement
approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P240044